Salta al contenuto principale
Facebook
Tweet
Digg it
Stumbleupon
Delicious
Plus Share
IT
EN
Form di ricerca
Ricerca
Center for Research in Neurobiology 'Daniel Bovet'
Toggle navigation
HOME
CRiN
Governance
A short history
Steering committee
Bandi Trasparenza
Bandi di gara
People
Speakers and Visiting
All members
Principal investigators
Research
Departments - CRiN
Institutions
Research Themes
Ongoing projects
News
Contact us
Keyword search
Terza Missione
CIVIS
Students
NeuroBlog
Home
01a Articolo in rivista
01a Articolo in rivista
Altered serum levels of kynurenine metabolites in patients affected by cluster headache
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans.
Anti-absence activity of mGlu1 and mGlu5 receptor enhancers and their interaction with a GABA reuptake inhibitor: Effect of local infusions in the somatosensory cortex and thalamus
Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis
mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system
Dickkopf-3 upregulates VEGF in cultured human endothelial cells by activating activin receptor-like Kinase 1 (ALK1) Pathway
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration
Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia
« prima
‹ precedente
…
103
104
105
106
107
108
109
110
111
…
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma
Accessibilità